GSTM1 and thalassemia: In a micromapping study recently carried out in northeast Thailand, we have identified prevalence of 41.7% for Hb E, 5.8% for α0-thalassemia, 31.4% for α+-thalassemia and 0.9% for β-thalassemia [11].